In Sequence: a genomics podcast by Genuity Science
In Sequence: a genomics podcast by Genuity Science
4 episodes
6 months ago
In episode 8, we talk to Dr. Scott Friedman, internationally renowned physician and scientist, who explains why Non-alcoholic steatohepatitis or NASH is a liver disease that is becoming a growing health concern world-wide. Dr. Friedman describes the extraordinary capacity for the liver to regenerate, his ground-breaking research into the cause of inflammation and resulting scarring or fibrosis of the liver, and how Whole Genome Sequencing is being used to improve our understanding of why some people have a higher risk of developing the condition than others. Finally, he talks about how drug companies are leveraging all of this growing information in order to develop better diagnostics and new effective treatments for NASH and other forms of chronic liver disease.
All content for In Sequence: a genomics podcast by Genuity Science is the property of In Sequence: a genomics podcast by Genuity Science and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In episode 8, we talk to Dr. Scott Friedman, internationally renowned physician and scientist, who explains why Non-alcoholic steatohepatitis or NASH is a liver disease that is becoming a growing health concern world-wide. Dr. Friedman describes the extraordinary capacity for the liver to regenerate, his ground-breaking research into the cause of inflammation and resulting scarring or fibrosis of the liver, and how Whole Genome Sequencing is being used to improve our understanding of why some people have a higher risk of developing the condition than others. Finally, he talks about how drug companies are leveraging all of this growing information in order to develop better diagnostics and new effective treatments for NASH and other forms of chronic liver disease.
Ep 5: Probing the Pandemic - Applying genomic research to accelerate our understanding of COVID-19
In Sequence: a genomics podcast by Genuity Science
40 minutes 39 seconds
4 years ago
Ep 5: Probing the Pandemic - Applying genomic research to accelerate our understanding of COVID-19
In episode 5, we hear from Professor Ross McManus, Professor in molecular medicine at Trinity College Dublin, who talks about his current research on people’s immune response to COVID-19. He also discusses how genomic is helping to accelerate our understanding of COVID-19 and how it can be applied to help develop better treatments in the future. We also hear from Britta Wyatt who shares her experience with Long COVID and how it has impacted her life over the past 9 months.
In Sequence: a genomics podcast by Genuity Science
In episode 8, we talk to Dr. Scott Friedman, internationally renowned physician and scientist, who explains why Non-alcoholic steatohepatitis or NASH is a liver disease that is becoming a growing health concern world-wide. Dr. Friedman describes the extraordinary capacity for the liver to regenerate, his ground-breaking research into the cause of inflammation and resulting scarring or fibrosis of the liver, and how Whole Genome Sequencing is being used to improve our understanding of why some people have a higher risk of developing the condition than others. Finally, he talks about how drug companies are leveraging all of this growing information in order to develop better diagnostics and new effective treatments for NASH and other forms of chronic liver disease.
